And now the soft-bashing begins. OH MY GOODNESS: what a debate. Should I buy a company with 3 drugs in multiple successful clinical trials for totally different applications NOW, when the market cap is 80 million (priced at less than the valuation of companies with no drugs in clinical trials) -- or should I let the shorts cover first, and let the trading gangs that are buying at low prices complete their positions, and THEN buy when I can pay a lot more?

Golly, gee, what a difficult decision.

Anyone having any doubts about the agenda of the latest multi-identity should have them resolved now.

EDIT: I know that it is irritating to see this latest manifestation, but the best thing to do now is NOT let him do what he wants -- which is to get people to post about this, refuting his lies, and thus giving his BS more exposure to any unwary newbies who might actually think this is a worthwhile subject for debate -- which it isn't.